BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33962751)

  • 1. Actin dynamics during tumor cell dissemination.
    Mondal C; Di Martino JS; Bravo-Cordero JJ
    Int Rev Cell Mol Biol; 2021; 360():65-98. PubMed ID: 33962751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells.
    Shankar J; Messenberg A; Chan J; Underhill TM; Foster LJ; Nabi IR
    Cancer Res; 2010 May; 70(9):3780-90. PubMed ID: 20388789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The actin cytoskeleton in cancer cell motility.
    Olson MF; Sahai E
    Clin Exp Metastasis; 2009; 26(4):273-87. PubMed ID: 18498004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
    Huang D; Cao L; Zheng S
    J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actin cytoskeleton in mesenchymal-to-amoeboid transition of cancer cells.
    Alexandrova AY; Chikina AS; Svitkina TM
    Int Rev Cell Mol Biol; 2020; 356():197-256. PubMed ID: 33066874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway.
    Jeong YJ; Hwang SK; Magae J; Chang YC
    Cell Oncol (Dordr); 2020 Oct; 43(5):793-805. PubMed ID: 32488849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMT, the cytoskeleton, and cancer cell invasion.
    Yilmaz M; Christofori G
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):15-33. PubMed ID: 19169796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of actin assembly to target tumor cell motility.
    Nürnberg A; Kollmannsperger A; Grosse R
    Rev Physiol Biochem Pharmacol; 2014; 166():23-42. PubMed ID: 24193252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Actin Dynamics and Actin-Binding Proteins Expression in Epithelial-to-Mesenchymal Transition and Its Association with Cancer Progression and Evaluation of Possible Therapeutic Targets.
    Izdebska M; Zielińska W; Grzanka D; Gagat M
    Biomed Res Int; 2018; 2018():4578373. PubMed ID: 29581975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed cell invasion and migration during metastasis.
    Bravo-Cordero JJ; Hodgson L; Condeelis J
    Curr Opin Cell Biol; 2012 Apr; 24(2):277-83. PubMed ID: 22209238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells.
    Sousa-Squiavinato ACM; Rocha MR; Barcellos-de-Souza P; de Souza WF; Morgado-Diaz JA
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):418-429. PubMed ID: 30296500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does fascin promote cancer metastasis?
    Lin S; Taylor MD; Singh PK; Yang S
    FEBS J; 2021 Mar; 288(5):1434-1446. PubMed ID: 32657526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-level control of actin dynamics by protein kinase D.
    Olayioye MA; Barisic S; Hausser A
    Cell Signal; 2013 Sep; 25(9):1739-47. PubMed ID: 23688773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The store-operated calcium channels in cancer metastasis: from cell migration, invasion to metastatic colonization.
    Mo P; Yang S
    Front Biosci (Landmark Ed); 2018 Jan; 23(7):1241-1256. PubMed ID: 28930597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin filaments at the leading edge of cancer cells are characterized by a high mobile fraction and turnover regulation by profilin I.
    Lorente G; Syriani E; Morales M
    PLoS One; 2014; 9(1):e85817. PubMed ID: 24465723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The actin cytoskeleton in normal and pathological cell motility.
    Lambrechts A; Van Troys M; Ampe C
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1890-909. PubMed ID: 15203104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the actin cytoskeleton in cancer cell migration and invasion.
    Yamaguchi H; Condeelis J
    Biochim Biophys Acta; 2007 May; 1773(5):642-52. PubMed ID: 16926057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence.
    Kelley LC; Hayes KE; Ammer AG; Martin KH; Weed SA
    PLoS One; 2010 Nov; 5(11):e13847. PubMed ID: 21079800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice.
    Peng JM; Bera R; Chiou CY; Yu MC; Chen TC; Chen CW; Wang TR; Chiang WL; Chai SP; Wei Y; Wang H; Hung MC; Hsieh SY
    Hepatology; 2018 Jun; 67(6):2226-2243. PubMed ID: 29171033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.